SigmaSreening – Amsterdam Academic Ventures

Our portfolio

SigmaSreening

SigmaScreening has developed a mammography device that reduces pain and improves diagnostic accuracy. Founded by Amsterdam UMC professors, the company aims to enhance breast cancer detection with their patented technology. SigmaScreening has licensed their technology to Teledyne, who continue development of the device.

Industry: Imaging, Medical Technology, Oncology

Want to get in contact about SigmaSreening?

We’re happy to connect. Reach out to our investment manager working with the team to learn more or explore potential opportunities.

Marc Roelofs

Life Science & Health

Our portfolio

Check out similar ventures

Transforming content into audio-based e-learning for on-the-go learning.

Developing rapid human gut microbiota analysis.

Advancing new therapeutics for Type 1 Diabetes and autoimmune diseases.

Enhancing patient care with AI-driven radiology solutions for clinical practice.

Transforming content into audio-based e-learning for on-the-go learning.

Developing rapid human gut microbiota analysis.

Advancing new therapeutics for Type 1 Diabetes and autoimmune diseases.

Enhancing patient care with AI-driven radiology solutions for clinical practice.